Abstract PO-003: Peripheral Blood and Tumor Tissue Biomarkers Associated with Epcoritamab Response in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: Data from the Dose-Expansion Cohort of the Phase 1/2 EPCORE NHL-1 Trial (NCT03625037)
Blood cancer discovery（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined